Oxcarbazepine Adjunctive Therapy for Partial Seizures

J Gordon Millichap

doi:10.15844/pedneurbriefs-14-7-6

Oxcarbazepine Adjunctive Therapy for Partial Seizures

Pediatric Neurology Briefs

Volume 14 (2000): Issue 7

By: J Gordon Millichap

Open Access

|Jul 2000

Abstract

The safety and efficacy of oxcarbazepine (OXC) as adjunctive therapy for refractory partial seizures were evaluated in 267 patients in a multicenter (47 centers in 8 countries; Argentina, Chile, Uruguay, Australia, New Zealand, Canada, Israel, and the USA), randomized, placebo-controlled trial, and reported from the Children’s Hospital, Cincinnati, OH.

References

Glauser TA Nigro M Sachdeo R Pasteris LA Weinstein S Abou-Khalil B Adjunctive therapy with oxcarbazepine in children with partial seizures Neurology 2000 Jun 27 54 12 2237 2244 10.1212/WNL.54.12.2237 10881246
Open DOI Search in Google Scholar Back to article
Beydoun A Sachdeo RC Rosenfeld WE Krauss GL Sessler N Mesenbrink P Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial Neurology 2000 Jun 27 54 12 2245 2251 10.1212/WNL.54.12.2245 10881247
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-14-7-6 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 52 - 52

Published on: Jul 1, 2000

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Oxcarbazepine,

Adjunctive Antiepileptic Therapy,

Placebo-Controlled Trial

© 2000 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 14 (2000): Issue 7